Gregory M. Glenn, President, R&D at NOVAVAX INC (NVAX), sold 10,500 shares at $188.33 ($1.9M) on 2021-11-02, disclosed to the SEC on 2021-11-04.
Open-market sale of $1.9M NVAX by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $177.12 | 600 | $106K | 5.5% |
| 2 | $178.12 | 1,200 | $214K | 11.1% |
| 3 | $179.09 | 900 | $161K | 8.3% |
| 4 | $180.41 | 600 | $108K | 5.6% |
| 5 | $181.55 | 670 | $122K | 6.3% |
| 6 | $181.55 | 670 |
| $122K |
| 6.3% |
| 7 | $182.58 | 600 | $110K | 5.7% |
| 8 | $182.58 | 600 | $110K | 5.7% |
| 9 | $183.58 | 800 | $147K | 7.6% |
| 10 | $184.82 | 302 | $56K | 2.9% |
| 11 | $184.82 | 302 | $56K | 2.9% |
| 12 | $186.09 | 500 | $93K | 4.8% |
| 13 | $187.26 | 300 | $56K | 2.9% |
| 14 | $188.33 | 300 | $56K | 2.9% |
| 15 | $188.33 | 300 | $56K | 2.9% |
| 16 | $190.29 | 100 | $19K | 1.0% |
| 17 | $193.16 | 400 | $77K | 4.0% |
| 18 | $194.40 | 300 | $58K | 3.0% |
| 19 | $195.54 | 378 | $74K | 3.8% |
| 20 | $195.54 | 378 | $74K | 3.8% |
| 21 | $196.24 | 200 | $39K | 2.0% |
| 22 | $197.51 | 100 | $20K | 1.0% |
| Total | $184.19 avg | 10,500 | $1.9M | 100% |
| Filing → |
| NVAX | SELL | 2021-12-09 | $1.6M | — | Filing → |
| NVAX | SELL | 2021-12-02 | $3.2M | — | Filing → |
| NVAX | SELL | 2021-11-30 | $719K | — | Filing → |